News
Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.
Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...
Yonhap News Agency on MSN1d
Celltrion expects minimal impact from Trump's drug pricing orderCelltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will remain largely unaffected ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...
StockStory.org on MSN2d
PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline ProductivityGlobal pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback